Astrocyte Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Astrocyte Pharmaceuticals has raised $6.1M across 2 funding rounds on record, the most recent an undisclosed round of $110k announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Astrocyte Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Astrocyte Pharmaceuticals Funding Rounds
Astrocyte Pharmaceuticals raised $6.0M in a Series B announced in Aug 2023.
1.3 years later, an undisclosed round of $110k was announced in Dec 2024.
Astrocyte Pharmaceuticals Founders and Leadership Team
Contact details for the Astrocyte Pharmaceuticals team: 2 of 2 have an email address on file.
Start 14-day free trial →Astrocyte Pharmaceuticals Funding Compared to Other Biotechnology Startups
Astrocyte Pharmaceuticals' latest round of $110k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Astrocyte Pharmaceuticals in Biotechnology and Cambridge
Companies Similar to Astrocyte Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Astrocyte Pharmaceuticals Funding FAQs
What does Astrocyte Pharmaceuticals do?
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
How much funding has Astrocyte Pharmaceuticals raised?
Astrocyte Pharmaceuticals has raised $6.1M across 2 rounds on record. The most recent is an undisclosed round of $110k announced in Dec 2024.
When did Astrocyte Pharmaceuticals last raise funding?
Astrocyte Pharmaceuticals' most recent funding round on record is an undisclosed round of $110k, announced in Dec 2024.
Who founded Astrocyte Pharmaceuticals?
FundedIQ lists James Lechleiter (Founder), William Korinek (Founder) at Astrocyte Pharmaceuticals.
Where is Astrocyte Pharmaceuticals headquartered?
Astrocyte Pharmaceuticals is based in Cambridge, Massachusetts, United States.
How many employees does Astrocyte Pharmaceuticals have?
Astrocyte Pharmaceuticals is in the 1-10 employee band.
How does Astrocyte Pharmaceuticals' funding compare to other Biotechnology startups?
Astrocyte Pharmaceuticals' latest round of $110k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Astrocyte Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Astrocyte Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.